Community-Based Eye Screening With Structured Referral Tracking for Preventing Avoidable Blindness in Adults in Rawalpindi, Pakistan (SIGHT)

June 2, 2026 updated by: Khizar Nabeel, Health Services Academy, Islamabad, Pakistan

Community-Based Eye Screening With a Structured Referral Tracking Intervention for the Prevention of Avoidable Blindness Among Adults in Rawalpindi District, Pakistan

This cluster randomized controlled trial aims to evaluate the effectiveness of a Structured Referral Tracking (SRT) intervention in improving referral completion among adults identified with avoidable blindness during community-based eye screening camps in Rawalpindi District, Pakistan. Ten community clusters will be randomized into intervention and control groups. Participants in the intervention group will receive structured referral counseling, weekly reminder calls or messages, and customized referral guidance for eight weeks, while the control group will receive standard referral procedures. The primary outcome is referral completion at a tertiary eye hospital within eight weeks after screening. Secondary outcomes include knowledge regarding avoidable blindness, treatment satisfaction, feasibility, acceptability, and barriers influencing referral completion.

Study Overview

Status

Not yet recruiting

Detailed Description

Avoidable blindness remains a major public health challenge in low- and middle-income countries, including Pakistan. Community-based eye screening camps are commonly used to identify individuals with visual impairment and eye diseases requiring treatment; however, referral completion to tertiary eye care facilities remains poor. Many patients fail to attend referral hospitals because of limited awareness, lack of follow-up, transportation barriers, and uncertainty regarding treatment procedures.

This study aims to evaluate the effectiveness and implementation of a Structured Referral Tracking (SRT) intervention in improving referral completion among adults identified with avoidable blindness during community-based eye screening camps in Rawalpindi District, Pakistan.

The study will use a cluster randomized controlled trial design. Ten community clusters (union councils) from five tehsils of Rawalpindi District will be selected using multistage random sampling. Clusters will be randomized into intervention and control arms. Participants attending eye screening camps who are diagnosed with eye conditions requiring referral to a tertiary eye hospital will be enrolled after informed consent.

Participants in the intervention arm will receive a multi-component Structured Referral Tracking intervention consisting of referral counseling, weekly reminder calls or mobile messages, visual educational material, and customized referral guidance regarding hospital location, estimated costs, and required documents. Participants in the control arm will receive standard referral procedures consisting of routine counseling and referral slips without structured follow-up.

The primary outcome will be referral completion at the tertiary eye hospital within eight weeks after screening, verified through hospital attendance records. Secondary outcomes will include knowledge regarding avoidable blindness, treatment satisfaction, feasibility and acceptability of the intervention, and barriers influencing referral completion.

The findings of this study are expected to provide evidence regarding the effectiveness and feasibility of structured referral tracking systems for improving eye care service utilization and reducing avoidable blindness in Pakistan.

Study Type

Interventional

Enrollment (Estimated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Khizar Nabeel, PHD (In progress)
  • Phone Number: +923455096776
  • Email: khizar@hsa.edu.pk

Study Locations

    • Punjab Province
      • Rawalpindi, Punjab Province, Pakistan, 46600
        • ACCO Department, Al-Shifa Trust Eye Hospital, Rawalpindi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 years or above
  • Individuals diagnosed with visual impairment or eye conditions requiring referral to a tertiary eye care facility
  • Permanent residents of Rawalpindi District, Pakistan
  • Willing and able to provide informed consent

Exclusion Criteria:

  • Individuals already undergoing treatment for the identified eye condition
  • Individuals requiring emergency ophthalmic care
  • Severe systemic or physical illness limiting follow-up
  • Individuals unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Structured Referral Tracking (SRT)
Participants will receive structured referral counseling, weekly reminder calls or messages, visual educational material, and customized referral guidance for eight weeks following community-based eye screening.
A multi-component referral tracking intervention including referral counseling, weekly reminder calls or mobile messages, visual educational material, and customized referral guidance to improve referral completion after community eye screening.
No Intervention: Standard Referral Procedure
Participants will receive routine referral slips and standard counseling without structured follow-up or reminder communication.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Referral Completion Rate Verified Through Hospital Records
Time Frame: Within 8 weeks after community eye screening
Proportion of referred participants who complete referral visits at the tertiary eye hospital, verified through hospital attendance records.
Within 8 weeks after community eye screening

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge Score on Avoidable Blindness Questionnaire
Time Frame: Baseline and 8 weeks after screening
Participant knowledge regarding avoidable blindness and eye health assessed using a structured questionnaire developed for the study.
Baseline and 8 weeks after screening
Participant Acceptability of Structured Referral Tracking Assessed Using Structured Feedback Questionnaire
Time Frame: Within 8 weeks after screening
Participant acceptability of the Structured Referral Tracking intervention assessed using a structured feedback questionnaire regarding usefulness and satisfaction with reminder communication.
Within 8 weeks after screening
Barriers Influencing Referral Completion Assessed Using Structured Barrier Assessment Questionnaire
Time Frame: Within 8 weeks after screening
Barriers and facilitators influencing referral completion assessed using a structured questionnaire among referred participants.
Within 8 weeks after screening

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Treatment Satisfaction Score Using Structured Satisfaction Questionnaire
Time Frame: Within 8 weeks after screening
Participant-reported satisfaction regarding referral services and treatment received at the tertiary eye hospital assessed using a structured satisfaction questionnaire.
Within 8 weeks after screening
Feasibility of Structured Referral Tracking Assessed by Reminder Delivery and Follow-up Completion Rates
Time Frame: Within 8 weeks after screening
Feasibility of the intervention assessed through successful delivery of reminder messages/calls and completion of scheduled follow-up procedures.
Within 8 weeks after screening

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Dr. Ahmad Abdullah, PHD, Shifa International Hospital, Islamabad

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

May 13, 2026

First Submitted That Met QC Criteria

May 20, 2026

First Posted (Actual)

May 28, 2026

Study Record Updates

Last Update Posted (Actual)

June 4, 2026

Last Update Submitted That Met QC Criteria

June 2, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

De-identified individual participant data underlying the published results may be shared upon reasonable request after publication of the primary study findings.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetic Retinopathy

Clinical Trials on Structured Referral Tracking (SRT)

Subscribe